Le Lézard
Classified in: Health
Subject: SVY

Global Hereditary Angioedema Therapeutics Market 2018-2022


LONDON, Sept. 25, 2018 /PRNewswire/ -- Hereditary angioedema is a rare genetic disease characterized by swelling of various parts of the body. The swelling is mainly observed in the face region and airways. It also leads to abdominal cramping.


Download the full report: https://www.reportbuyer.com/product/5570390


Technavio's analysts forecast the Global Hereditary Angioedema Therapeutics Market to grow at a CAGR of 8.94% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the hereditary angioedema therapeutics market. To calculate the market size, the report considers the revenue generated from the hereditary angioedema therapeutics.

Technavio's report, hereditary angioedema therapeutics market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The market is divided into the following segments based on geography:
? Americas
? APAC
? EMEA

Key vendors
? BioCryst Pharmaceuticals
? Cipla
? CSL
? Pharming Group
? Shire

Market driver
? Increasing prevalence of hereditary angioedema
? For a full, detailed list, view our report

Market challenge
? High cost of treatment
? For a full, detailed list, view our report

Market trend
? Innovative treatment strategies
? For a full, detailed list, view our report

Key questions answered in this report
? What will the market size be in 2022 and what will the growth rate be?
? What are the key market trends?
? What is driving this market?
? What are the challenges to market growth?
? Who are the key vendors in this market space?
? What are the market opportunities and threats faced by the key vendors?
? What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Download the full report: https://www.reportbuyer.com/product/5570390

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com

SOURCE ReportBuyer


These press releases may also interest you

at 09:00
Dental Care Acworth is thrilled to utilize this remarkable innovation and offer patients unbiased, objective and standardized dental care that they know they can trust. The AI solutions Pearl delivers can assist dental...

at 09:00
Tolland Hill Family Dental is thrilled to announce the addition of Dr. Conway Ma to its esteemed team of dental professionals. Tolland Hill Family Dental offers a wide range of services, catering to patients of all ages. From a child's first dental...

at 09:00
Amgen today announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for teprotumumab, a fully human monoclonal antibody and targeted inhibitor of the insulin-like growth factor-1...

at 09:00
Ractigen Therapeutics, a leader in the development of small activating RNA (saRNA) therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application for RAG-01, a...

at 09:00
Arbele, a clinical-stage biotechnology company focused...

at 08:53
Alera Health, a leader in population health management integrating behavioral healthcare, is proud to announce its recognition as one of the Great Employers to Work for in North Carolina by Best Companies Group. The 2024 Great Employers to Work for...



News published on and distributed by: